Additional studies demonstrate that tumor-derived EVs could influence the breast cancer cells’ invasion through differential glycosylation of EMMPRIN, associated with p38/MAPK signaling pathway, which is activated by EMMPRIN-containing EVs [80]. The gene discussed is BSG; the disease is neoplasm.